Overview

The marketing authorisation for Coliprotec F4 has been withdrawn at the request of the marketing authorisation holder.

Coliprotec F4 : EPAR - Summary for the public

български (BG) (339.6 KB - PDF)
español (ES) (280.56 KB - PDF)
čeština (CS) (323.58 KB - PDF)
dansk (DA) (282.05 KB - PDF)
Deutsch (DE) (283.88 KB - PDF)
eesti keel (ET) (279.13 KB - PDF)
ελληνικά (EL) (557.37 KB - PDF)
français (FR) (283.25 KB - PDF)
hrvatski (HR) (302.5 KB - PDF)
italiano (IT) (281.12 KB - PDF)
latviešu valoda (LV) (335.77 KB - PDF)
lietuvių kalba (LT) (303.43 KB - PDF)
magyar (HU) (324.05 KB - PDF)
Malti (MT) (328.9 KB - PDF)
Nederlands (NL) (281.07 KB - PDF)
polski (PL) (326.11 KB - PDF)
português (PT) (281.38 KB - PDF)
română (RO) (302.61 KB - PDF)
slovenčina (SK) (324.12 KB - PDF)
slovenščina (SL) (321.83 KB - PDF)
Suomi (FI) (279.66 KB - PDF)
svenska (SV) (281.24 KB - PDF)

Product information

Coliprotec F4 : EPAR - Product Information

български (BG) (1012.78 KB - PDF)
español (ES) (820.71 KB - PDF)
čeština (CS) (908 KB - PDF)
dansk (DA) (826.6 KB - PDF)
Deutsch (DE) (869.55 KB - PDF)
eesti keel (ET) (816.49 KB - PDF)
ελληνικά (EL) (780.33 KB - PDF)
français (FR) (793.01 KB - PDF)
hrvatski (HR) (769.61 KB - PDF)
íslenska (IS) (798.87 KB - PDF)
italiano (IT) (978.35 KB - PDF)
latviešu valoda (LV) (931.25 KB - PDF)
lietuvių kalba (LT) (774.14 KB - PDF)
magyar (HU) (906.99 KB - PDF)
Malti (MT) (925.67 KB - PDF)
Nederlands (NL) (834.16 KB - PDF)
norsk (NO) (716.7 KB - PDF)
polski (PL) (905.37 KB - PDF)
português (PT) (871.1 KB - PDF)
română (RO) (468.63 KB - PDF)
slovenčina (SK) (913.49 KB - PDF)
slovenščina (SL) (1005.42 KB - PDF)
Suomi (FI) (754.69 KB - PDF)
svenska (SV) (824.08 KB - PDF)

Latest procedure affecting product information: R/0005

15/01/2020

Coliprotec F4 : EPAR - All Authorised presentations

български (BG) (249.1 KB - PDF)
español (ES) (233.3 KB - PDF)
čeština (CS) (252.59 KB - PDF)
dansk (DA) (225 KB - PDF)
Deutsch (DE) (235.85 KB - PDF)
eesti keel (ET) (233.53 KB - PDF)
ελληνικά (EL) (255.99 KB - PDF)
français (FR) (235.07 KB - PDF)
hrvatski (HR) (243.63 KB - PDF)
íslenska (IS) (251.63 KB - PDF)
italiano (IT) (233.9 KB - PDF)
latviešu valoda (LV) (255.18 KB - PDF)
lietuvių kalba (LT) (251.38 KB - PDF)
magyar (HU) (255.53 KB - PDF)
Malti (MT) (255.1 KB - PDF)
Nederlands (NL) (234.69 KB - PDF)
norsk (NO) (249.14 KB - PDF)
polski (PL) (255.19 KB - PDF)
português (PT) (226.91 KB - PDF)
română (RO) (245.41 KB - PDF)
slovenčina (SK) (257.55 KB - PDF)
slovenščina (SL) (253.51 KB - PDF)
Suomi (FI) (234.94 KB - PDF)
svenska (SV) (234.66 KB - PDF)

Product details

Name of medicine
Coliprotec F4
Active substance
live non-pathogenic Escherichia coli O8:K87
International non-proprietary name (INN) or common name
Escherichia coli, type 08, strain K87 (live)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AE03

Pharmacotherapeutic group

  • Immunologicals for suidae
  • Live bacterial vaccines
  • Pig

Therapeutic indication

For active immunisation of pigs against enterotoxigenic F4-positive Escherichia coli in order to:

  • reduce the incidence of moderate to severe post-weaning Escherichia coli diarrhoea (PWD) in pigs;
  • reduce the colonisation of the ileum and faecal shedding of enterotoxigenic F4-positive Escherichia coli from infected pigs.

Authorisation details

EMA product number
EMEA/V/C/003797
Marketing authorisation holder
Prevtec Microbia GmbH

Geyerspergerstrasse 27
80689 München
Germany

Marketing authorisation issued
16/03/2015
Revision
2

Assessment history

Coliprotec F4 : EPAR - Procedural steps taken and scientific information after authorisation

Coliprotec F4 : EPAR - Public assessment report

CVMP summary of positive opinion for Coliprotec F4

Topics

This page was last updated on

How useful do you find this page?